Synthesis and chiroptical characterization of prostacyclin diastereomers.

[1]  K. Nicolaou,et al.  SYNTHESIS AND BIOLOGICAL PROPERTIES OF PROSTACYCLINS AND PROSTAGLANDIN ENDOPEROXIDE ANALOGS , 1979 .

[2]  Roy A. Johnson,et al.  Synthesis and characterization of prostacyclin, 6-ketoprostaglandin F1.alpha., prostaglandin I1, and prostaglandin I3 , 1978 .

[3]  J. C. Sih,et al.  Oxidative ozonolysis of 6-oxo-PGF1α, 11,15-diacetate, methyl acetal, methyl ester , 1978 .

[4]  M. Cho,et al.  Chemical stability of prostacyclin (PGI2) in aqueous solutions. , 1978, Prostaglandins.

[5]  G. Gasic,et al.  Synthesis and biological properties of prostaglandin endoperoxides, thromboxanes and prostacyclins. , 1978, Angewandte Chemie.

[6]  R. A. Johnson,et al.  Synthesis of the four isomers of 5-hydroxy-PGI1. , 1978, Prostaglandins.

[7]  N. Whittaker.  A synthesis of prostacyclin sodium salt , 1977 .

[8]  N. A. Nelson.  Stereoconfiguration of 5,6-dihydroprostacyclins. , 1977, Journal of the American Chemical Society.

[9]  V. Simonidesz,et al.  A simple synthesis of PGI2 , 1977 .

[10]  K. Nicolaou,et al.  Synthesis of (4E)-9-deoxy-6,9α-epoxy-Δ4-PGF1α, a prostacyclin (PGX) isomer , 1977 .

[11]  C. Sih,et al.  Concerning the biosynthesis of prostaglandin I2 , 1977 .

[12]  N. Andersen,et al.  Synthesis of diastereomeric bis-unsaturated prostaglandins. , 1977, Prostaglandins.

[13]  R. A. Johnson,et al.  Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha. , 1977, Journal of the American Chemical Society.

[14]  J. Fried,et al.  Synthesis of 13,14-dehydroprostacyclin methyl ester: a potent inhibitor of platelet aggregation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Corey,et al.  Synthesis of Vane's prostaglandin X, 6,9alpha-oxido9alpha,15alpha-dihydroxyprosta-(Z)5,(E)13-dienoic acid. , 1977, Journal of the American Chemical Society.

[16]  R. A. Johnson,et al.  The chemical structure of prostaglandin X (prostacyclin). , 1976, Prostaglandins.

[17]  J. Vane,et al.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. , 1976, Prostaglandins.

[18]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.

[19]  N. Andersen,et al.  Letter: Molecular basis for prostaglandin potency. I. The case for biological significance of media dependent conformational changes. , 1975, Journal of the American Chemical Society.

[20]  N. Andersen,et al.  Identification and quantitative determination of prostaglandins by high pressure liquid chromatography. , 1974, Prostaglandins.

[21]  N. Andersen,et al.  Optical activity associated with isolated olefinic bonds. II. Experimental evidence for the role of .pi.-bond torsion in circular dichroism couplets and the question of .sigma.a .far. .pi.x* contributions , 1974 .

[22]  N. Andersen,et al.  Optical activity associated with isolated olefinic bonds. I. Allylic bond polarization (ABP) model and its extension to homoconjugated systems , 1973 .

[23]  E. Corey,et al.  11,15-Epiprostaglandin E 2 and its enantiomer. Biological activity and synthesis. , 1972, The Journal of organic chemistry.

[24]  N. Andersen.  Preparative thin-layer and column chromatography of prostaglandins , 1969 .

[25]  M. Waterfield,et al.  Quantitative Approach to the Sequential Degradation of Proteins and Peptides , 1969, Nature.

[26]  E. Corey,et al.  Biological Activity of Synthetic Prostaglandins , 1969, Nature.

[27]  A. Kresge,et al.  Acid-catalysed hydrolysis of prostacyclin: origin of the unused lability , 1979 .

[28]  L. Radics,et al.  Stereochemistry of 5-bromo-and 5-iodo-5,6-dihydroprostacyclin and related bicyclic ethers , 1978 .

[29]  E. Corey,et al.  Configuration at C-6 of 6,9α-oxido-bridged prostaglandins , 1978 .

[30]  G. Gasic,et al.  Simple efficient synthesis of prostacyclin (PGI2)1 , 1977 .

[31]  W. L. Miller,et al.  Relative biological activity of certain prostaglandins and their enantiomers. , 1976, Prostaglandins.

[32]  N. Andersen,et al.  Biological consequences of prostaglandin molecular conformations. , 1976, Advances in prostaglandin and thromboxane research.

[33]  C. Gandolfi,et al.  Prostagiandins IX: 8,12-diiso-PGE2: Effect of steric configuration of side chains on biological activity , 1975 .

[34]  N. Andersen,et al.  Biological Aspects of Prostaglandins , 1974 .